These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1321052

  • 21. Mechanisms of erythroid suppression in the anemia of chronic disease.
    Roodman GD.
    Blood Cells; 1987; 13(1-2):171-84. PubMed ID: 2822178
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In vivo infection of marrow stromal fibroblasts by feline leukemia virus.
    Linenberger ML, Abkowitz JL.
    Exp Hematol; 1992 Sep; 20(8):1022-7. PubMed ID: 1324184
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L, Walker D, Broxmeyer HE, Hoffman R, Hu W, Walker E.
    J Immunol; 1987 Sep 15; 139(6):1823-9. PubMed ID: 3114377
    [Abstract] [Full Text] [Related]

  • 27. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul 15; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates.
    Gallicchio VS, Casale GP, Watts T.
    Exp Hematol; 1987 Dec 15; 15(11):1099-102. PubMed ID: 3678410
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.
    Bonnet D, Lemoine FM, Najman A, Guigon M.
    Exp Hematol; 1995 Jun 15; 23(6):551-6. PubMed ID: 7539383
    [Abstract] [Full Text] [Related]

  • 35. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE, Lu L, Cooper S, Tushinski R, Mochizuki D, Rubin BY, Gillis S, Williams DE.
    J Immunol; 1988 Dec 01; 141(11):3852-62. PubMed ID: 3053902
    [Abstract] [Full Text] [Related]

  • 36. Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures.
    Lu L, Welte K, Gabrilove JL, Hangoc G, Bruno E, Hoffman R, Broxmeyer HE.
    Cancer Res; 1986 Sep 01; 46(9):4357-61. PubMed ID: 3089590
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of erythroid colony-forming cells by a Mr 15,000 protein of feline leukemia virus.
    Wellman ML, Kociba GJ, Lewis MG, Mathes LE, Olsen RG.
    Cancer Res; 1984 Apr 01; 44(4):1527-9. PubMed ID: 6322979
    [Abstract] [Full Text] [Related]

  • 38. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H, Little MT, Dragowska W, Thornbury G, Lansdorp PM.
    Exp Hematol; 1995 May 01; 23(5):422-7. PubMed ID: 7536684
    [Abstract] [Full Text] [Related]

  • 39. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).
    Johnson CS, Cook CA, Furmanski P.
    Exp Hematol; 1990 Feb 01; 18(2):109-13. PubMed ID: 2303102
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.